z-logo
Premium
Lack of effect of oral activated charcoal on imipramine clearance
Author(s) -
Goldberg Mark J,
Park Glen D,
Spector Reynold,
Fischer Lawrence J,
Feldman Ross D
Publication year - 1985
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.1985.184
Subject(s) - imipramine , activated charcoal , pharmacokinetics , volume of distribution , charcoal , crossover study , oral administration , dosing , pharmacology , chemistry , medicine , anesthesia , adsorption , alternative medicine , organic chemistry , pathology , placebo
The effect of oral activated charcoal on the pharmacokinetics of intravenous imipramine was studied in a randomized, crossover trial. Four normal men received intravenous imipramine (12.5 mg/70 kg) on two separate occasions, followed by either water or water plus high‐surface‐area activated charcoal (180 gm) in divided doses over 24 hours. Serum imipramine concentrations were measured from 0 to 24 hours after the imipramine infusion. There was no difference in the mean (± SE) t ½ (9.0 ± 0.8 vs. 10.9 ± 1.6 hours), apparent volume of distribution (11.2 ± 2.1 vs. 12.4 ± 2.1 L/kg), or systemic clearance (992.2 ± 138.3 vs. 930.3 ± 101.9 ml/min/70 kg) of imipramine after dosing without and with oral activated charcoal, respectively (P > 0.05; paired t test). These results suggest that multiple oral doses of activated charcoal do not increase the clearance of imipramine in man. Clinical Pharmacology and Therapeutics (1985) 38, 350–353; doi: 10.1038/clpt.1985.184

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom